申请人:Bavetsias Vassilios
公开号:US20090247507A1
公开(公告)日:2009-10-01
Compounds of formula (I), are aurora kinase inhibitors: wherein X is —N—, —CH2—N—, —CH2—CH—, or —CH—; R1 is a radical of formula (IA) wherein Z is —CH2—, —NH—, -0-, —S(O)— —S—, —S(O)2 or a divalent monocyclic carbocyclic or heterocyclic radical having 3-7 ring atoms; Alk is an optionally substituted divalent C1-C6 alkylene radical; A is hydrogen or an optionally substituted monocyclic carbocyclic or heterocyclic ring having 5-7 ring atoms; r, s and t are independently 0 or 1, provided that when A is hydrogen then at least one of r and s is 1; R2 is halogen, —CN, —CF3, —OCH3, or cyclopropyl; and R3 is a radical of formula (IB) wherein Q is hydrogen or an optionally substituted phenyl or monocyclic heterocyclic ring with 5 or 6 ring atoms; Z&It;1> is —S—, —S(O)—, —S(O)2—, —O—, —SO2NH—, —NHSO2—, NHC(═O)NH, —NH(C═S)NH—, Or —N(R4)—wherein R4 is hydrogen, C1-C3 alkyl, cycloalkyl, or benzyl; and Alk&It;1> and Alk&It;2> are, independently, optionally substituted divalent C1-C3 alkylene radicals; and m, n and p are independently 0 or 1. Data supplied from the esp@cenet datatbase—Worldwide d77
式(I)的化合物是极光激酶抑制剂:其中X是—N—、—CH2—N—、—CH2—CH—或—CH—;R1是式(IA)的基团,其中Z是—CH2—、—NH—、-O-、—S(O)—、—S—、—S(O)2或具有3-7个环原子的二价单环碳环或杂环基团;Alk是任选取代的二价C1-C6亚烷基基团;A是氢或任选取代的具有5-7个环原子的单环碳环或杂环环;r、s和t独立地为0或1,前提是当A为氢时,至少一个r和s为1;R2是卤素、—CN、—CF3、—OCH3或环丙基;R3是式(IB)的基团,其中Q是氢或任选取代的苯基或具有5或6个环原子的单环杂环环;Z<1>是—S—、—S(O)—、—S(O)2—、—O—、—SO2NH—、—NHSO2—、NHC(═O)NH、—NH(C═S)NH—或—N(R4)—,其中R4是氢、C1-C3烷基、环烷基或苄基;Alk<1>和Alk<2>独立地是任选取代的二价C1-C3亚烷基基团;m、n和p独立地为0或1。数据来自esp@cenet数据库—Worldwide d77。